Pediatric and Adolescent Oncofertility in Male Patients-From Alpha to Omega

Genes (Basel). 2021 May 8;12(5):701. doi: 10.3390/genes12050701.

Abstract

This article reviews the latest information about preserving reproductive potential that can offer enhanced prospects for future conception in the pediatric male population with cancer, whose fertility is threatened because of the gonadotoxic effects of chemotherapy and radiation. An estimated 400,000 children and adolescents aged 0-19 years will be diagnosed with cancer each year. Fertility is compromised in one-third of adult male survivors of childhood cancer. We present the latest approaches and techniques for fertility preservation, starting with fertility preservation counselling, a clinical practice guideline used around the world and finishing with recent advances in basic science and translational research. Improving strategies for the maturation of germ cells in vitro combined with new molecular techniques for gene editing could be the next scientific keystone to eradicate genetic diseases such as cancer related mutations in the offspring of cancer survivors.

Keywords: cancer; fertility preservation; in vitro spermatogenesis; oncofertility; pediatric; prepubertal boys.

Publication types

  • Review

MeSH terms

  • Adolescent
  • Antineoplastic Agents / adverse effects
  • Cancer Survivors*
  • Child
  • Fertility Preservation / methods*
  • Humans
  • Infertility, Male / etiology
  • Infertility, Male / therapy*
  • Male
  • Radiotherapy / adverse effects
  • Sperm Retrieval

Substances

  • Antineoplastic Agents